Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome.

作者: Steven Haugbøl , Lars H. Pinborg , Lisbeth Regeur , Elsebet S. Hansen , Tom G. Bolwig

DOI: 10.1017/S1461145706006559

关键词:

摘要: Experimental and clinical data have suggested that abnormalities in the serotonergic neurotransmissions frontal-subcortical circuits are involved Tourette's syndrome. To test hypothesis brain's 5-HT2A receptor binding is increased patients with syndrome, PET imaging was performed. Twenty adults syndrome 20 healthy control subjects were investigated PET- ( 18 F)altanserin using a bolus-infusion protocol. Regions of interest delineated automatically on co-registered MRI images, partial volume-corrected parameters extracted from images. Comparison between showed specific binding, not only a-priori selected brain regions hypothesized to be but also post-hoc analysis global up-regulation when testing for overall difference randomization (p<0.03). Increased found closely related subcortical most other regions. Our suggest transmitter system pathophysiologically trial antagonists may justified.

参考文章(46)
D E Comings, B G Comings, A controlled study of Tourette syndrome. V: Depression and mania American Journal of Human Genetics. ,vol. 41, pp. 804- 821 ,(1987)
D E Comings, B G Comings, A controlled study of Tourette syndrome. IV. Obsessions, compulsions, and schizoid behaviors. American Journal of Human Genetics. ,vol. 41, pp. 782- 803 ,(1987)
Ann M Graybiel, Juan J Canales, The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome. Advances in Neurology. ,vol. 85, pp. 123- 131 ,(2001)
BRIAN LOPRESTI, DANIEL HOLT, N. SCOTT MASON, YIYUN HUANG, JAMES RUSZKIEWICZ, JENNIFER PEREVUZNIK, JULIE PRICE, JAMES DAVIS, CHESTER MATHIS, GWENN SMITH, CHAPTER 44 – Characterization of the Radiolabeled Metabolites of [18F]Altanserin: Implications for Kinetic Modeling Quantitative Functional Brain Imaging with Positron Emission Tomography. pp. 293- 298 ,(1998) , 10.1016/B978-012161340-2/50046-9
T. G. Turkington, C. W. Stearns, J. M. Hoffman, R. E. Coleman, T. R. DeGrado, J. J. Williams, Performance characteristics of a whole-body PET scanner. The Journal of Nuclear Medicine. ,vol. 35, pp. 1398- 1406 ,(1994)
Ipe Ninan, Shrinivas K Kulkarni, 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. European Journal of Pharmacology. ,vol. 358, pp. 111- 116 ,(1998) , 10.1016/S0014-2999(98)00591-3
Lars H. Pinborg, Karen H. Adams, Stig Yndgaard, Steen G. Hasselbalch, Søren Holm, Heidi Kristiansen, Olaf B. Paulson, Gitte M. Knudsen, [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. Journal of Cerebral Blood Flow and Metabolism. ,vol. 24, pp. 1037- 1045 ,(2004) , 10.1097/01.WCB.0000126233.08565.E7
David E. Comings, Blood serotonin and tryptophan in Tourette syndrome. American Journal of Medical Genetics. ,vol. 36, pp. 418- 430 ,(1990) , 10.1002/AJMG.1320360410
Franz X Vollenweider, Peter Vontobel, Daniel Hell, Klaus L Leenders, 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride. Neuropsychopharmacology. ,vol. 20, pp. 424- 433 ,(1999) , 10.1016/S0893-133X(98)00108-0
Guy A. Higgins, Michel Enderlin, Marie Haman, Paul J. Fletcher, The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism Psychopharmacology. ,vol. 170, pp. 309- 319 ,(2003) , 10.1007/S00213-003-1549-0